HESTER BIOSCIENCES
Back to Balance Sheet
|
HESTER BIOSCIENCES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹678 Cr | ₹653 Cr | ₹662 Cr | ₹670 Cr | ₹562 Cr |
What is the latest Total Liabilities ratio of HESTER BIOSCIENCES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹678 Cr |
| Mar2025 | ₹653 Cr |
| Mar2024 | ₹662 Cr |
| Mar2023 | ₹670 Cr |
| Mar2022 | ₹562 Cr |
How is Total Liabilities of HESTER BIOSCIENCES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹678 Cr | 3.76 | |
| Mar2025 | ₹653 Cr | -1.35 | |
| Mar2024 | ₹662 Cr | -1.14 | |
| Mar2023 | ₹670 Cr | 19.18 | |
| Mar2022 | ₹562 Cr | - | |
Compare Total Liabilities of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹2,037.2 Cr | 15% | 22.3% | 41.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,507.0 Cr | 2.8% | 7.4% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹190,744.0 Cr | 6.4% | 8.3% | 0.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹168,250.0 Cr | 2.1% | 8.7% | 47.7% | Stock Analytics | |
| CIPLA | ₹116,213.0 Cr | 0.5% | 3.6% | -5.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,980.0 Cr | -7.6% | -2.2% | -5.8% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | 15% |
22.3% |
41.2% |
| SENSEX | -1.4% |
4.4% |
-7.6% |
You may also like the below Video Courses